Gilead officer plans Rule 144 sale of 3,000 shares

Johanna Mercier filed a Rule 144 notice to sell 3,000 Gilead Sciences common shares, following recent sales totaling 31,000 shares.

Rhea-AI Filing Summary

GILEAD SCIENCES, INC. (GILD) has a notice under Rule 144 for a planned sale of common stock by Johanna Mercier. The notice covers 3,000 shares of common stock to be sold through Morgan Stanley Smith Barney LLC, with an aggregate market value of $432,646.20 as of the filing. The shares to be sold were acquired as Performance Shares from the issuer on February 4, 2025, and are listed on NASDAQ.

In addition, Johanna Mercier reported prior sales of Gilead common stock during the past three months, including 28,000 shares on August 17, 2026 for $3,853,907.85 and 3,000 shares on July 15, 2026 for $389,757.60.

Key Figures

Shares proposed for sale: 3,000 shares Aggregate market value of proposed sale: $432,646.20 Acquisition date of shares: February 4, 2025 +4 more

7 metrics

Shares proposed for sale 3,000 shares Common stock covered by the current Rule 144 notice

Aggregate market value of proposed sale $432,646.20 Value of 3,000 common shares referenced in the notice

Acquisition date of shares February 4, 2025 Date Performance Shares were acquired from the issuer

Shares sold on August 17, 2026 28,000 shares Common stock sold in the past three months

Proceeds from August 17, 2026 sale $3,853,907.85 Aggregate sale price for 28,000 common shares

Shares sold on July 15, 2026 3,000 shares Common stock sold in the past three months

Proceeds from July 15, 2026 sale $389,757.60 Aggregate sale price for 3,000 common shares

Key Terms

Rule 144, Performance Shares, issuer, NASDAQ

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Performance Shares financial

"Common | 02/04/2025 | Performance Shares | ISSUER"

Performance shares are a type of company stock given to executives or employees that only become theirs if the company meets specific goals, like hitting certain profits or growth targets. They motivate leaders to work toward the company’s success, because their additional shares depend on achieving these results.

issuer regulatory

"Performance Shares | ISSUER | | | 3000"

NASDAQ market

"1239955155 | 09/15/2026 | NASDAQ"

The Nasdaq is a stock exchange where many companies' shares are bought and sold, functioning much like a marketplace for investments. It matters to investors because it provides a platform to buy and sell ownership stakes in companies, helping them track the value of those companies and make informed decisions. As one of the largest and most technology-focused markets, it also reflects trends and developments in the business world.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing disclose for GILD?

The filing reports that Johanna Mercier has notified of a proposed sale of 3,000 Gilead Sciences common shares under Rule 144 through Morgan Stanley Smith Barney LLC, with an indicated aggregate market value of $432,646.20.

How many Gilead (GILD) shares is Johanna Mercier proposing to sell now?

Johanna Mercier is proposing to sell 3,000 shares of Gilead Sciences common stock under Rule 144. The notice lists an aggregate market value of $432,646.20 for these shares at the time of the filing.

What Gilead (GILD) shares did Johanna Mercier sell in the past three months?

During the past three months, Johanna Mercier reported selling 28,000 Gilead common shares on August 17, 2026 for $3,853,907.85 and 3,000 shares on July 15, 2026 for $389,757.60.

How were the Gilead (GILD) shares in this Form 144 acquired?

The 3,000 Gilead Sciences common shares covered by this notice were acquired as Performance Shares from the issuer on February 4, 2025, according to the securities-to-be-sold section.

Through which broker will the Gilead (GILD) shares be sold under this Form 144?

The proposed sale of 3,000 Gilead Sciences common shares is listed as being through Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, New York.

On which market are the Gilead (GILD) shares in this Form 144 listed?

The common shares of Gilead Sciences referenced in this Form 144 notice are listed on NASDAQ, as indicated in the securities information section.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/15/2026 - 04:21 PM Accepted by SEC EDGAR 09/15/2026 - 04:20 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001782135
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	GILEAD SCIENCES, INC.
SEC File Number	000-19731
Address of Issuer	333 Lakeside Drive Foster City CALIFORNIA 94404
Phone	(650) 574-3000
Name of Person for Whose Account the Securities are To Be Sold	JOHANNA MERCIER
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	3000	432646.20	1239955155	09/15/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/04/2025	Performance Shares	ISSUER			3000	02/04/2025	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
JOHANNA MERCIER 333 Lakeside Drive Foster City CA 94404	Common	08/17/2026	28000	3853907.85
JOHANNA MERCIER 333 Lakeside Drive Foster City CA 94404	Common	07/15/2026	3000	389757.60

144: Remarks and Signature

Remarks
Date of Notice	09/15/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	02/20/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Johanna Mercier
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)